Navigation Links
New Drug Shows Significant Improvement In HIV-related Heart Condition

Latest research has shown that treatment with the oral drug bosentan (Tracleer) has led to significant improvements in an often fatal disease, pulmonary arterial hypertension ( PAH) // .

PAH is usually linked with human immunodeficiency virus infection. HIV infection is believed to cause the overproduction of endothelin, which increases the chance for small pulmonary arteries to become obstructed. This chronic obstruction leads to PAH, a condition that in most cases is the direct cause of death. Bosentan mediates the effects of excess endothelin production.

For the study 16 HIV-positive patients suffering from PAH who were treated with bosetan for 16 weeks were evaluated. Results showed there was significant improvement in survival indicators of the disease, such as six-minute walk distance and cardiac index, following bosetan treatment. However all patients suffered at least one adverse side effect of the drug including peripheral edema, headache, abnormal liver function, muscle cramps, fluid retention, and vomiting.

Page: 1

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. New Prostate Cancer Vaccine Shows Promise
3. Ebola Treatment Shows Promise
4. Greek Study Shows Living In The Hills May Be Healthier
5. Research Shows Carbon Monoxide Prevents Inflammations
6. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
7. Novartis MS Drug Shows Promising Results
8. MRI Shows Emotional Changes During Menstrual Cycle
9. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
10. AIDS drug GS 9137 Shows Promise
11. Teenager Shows Signs Of Recovery after Receiving Massive Dose of Radiation
Post Your Comments:

(Date:12/1/2015)... , ... December 01, 2015 , ... ... radiographic technicians must mark the film for accurate interpretation by the radiologist. The ... Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate this ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... (BHCOE) today announced that the organization has awarded Education and Developmental Therapies (EDT), ... Distinguished Award. The award celebrates exceptional special needs providers that excel in synthesizing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Lutronic, a leading ... Clarity, the latest addition to the devices for sale in the United States. ... Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 ... semi-finalists to head to Las Vegas for CES 2016, the world’s largest Consumer Electronic ... Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Nurotron Biotechnology Co., ... its largest order to date. , The order will be from the China ... Venus Cochlear Implant System is an effective solution for children and adults suffering from ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Athletic apparel ... founder have agreed to pay $1.35 million to ... advertised the company,s copper-infused compression clothing would relieve ... arthritis and other diseases. Tommie ... requires the company and its founder and chairman ...
(Date:12/1/2015)... , Dec. 1, 2015 Assurex Health, ... GeneSight® Psychotropic test giving healthcare providers an expanded range ... for patients suffering from depression, anxiety, bipolar disorder, ... health conditions. i .   ... With the addition of two new drug ...
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... products and services, announced today that it has been ... services organization. Members served by Novation will have access ... devices, sports bracing products and soft goods dedicated to ... --> The aging U.S. population, rising prevalence ...
Breaking Medicine Technology: